Connection

Felix Bongomin to Antifungal Agents

Back to Details
This is a "connection" page, showing publications Felix Bongomin has written about Antifungal Agents.
Felix Bongomin
Connection Strength
1.213
Antifungal Agents
  1. Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events. Mycoses. 2019 Mar; 62(3):217-222.
    View in: PubMed
    Score: 0.353
  2. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis. PLoS One. 2018; 13(4):e0193732.
    View in: PubMed
    Score: 0.334
  3. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species. Mycoses. 2018 May; 61(5):290-297.
    View in: PubMed
    Score: 0.331
  4. Sequence analysis of isolates of Aspergillus from patients with chronic and allergic aspergillosis reveals a spectrum of cryptic species. Future Microbiol. 2018 11; 13:1557-1563.
    View in: PubMed
    Score: 0.087
  5. Micafungin may be safely administered as outpatient parenteral antimicrobial therapy for chronic pulmonary aspergillosis. Mycoses. 2019 Feb; 62(2):152-156.
    View in: PubMed
    Score: 0.087
  6. Acute kidney injury: an unusual complication of posaconazole use. J Chemother. 2018 Oct - Dec; 30(6-8):380-383.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.